Kepler Capital Markets Analysts Give adidas (ADS) a €222.00 Price Target

Share on StockTwits

adidas (FRA:ADS) received a €222.00 ($258.14) price target from analysts at Kepler Capital Markets in a research note issued on Thursday. The firm currently has a “buy” rating on the stock. Kepler Capital Markets’ price target indicates a potential upside of 13.58% from the stock’s previous close.

A number of other equities analysts have also weighed in on ADS. Royal Bank of Canada set a €220.00 ($255.81) price target on shares of adidas and gave the company a “buy” rating in a report on Thursday, August 9th. Baader Bank set a €220.00 ($255.81) target price on shares of adidas and gave the company a “buy” rating in a research note on Thursday, August 9th. equinet set a €228.00 ($265.12) target price on shares of adidas and gave the company a “buy” rating in a research note on Thursday, August 9th. Macquarie set a €240.00 ($279.07) target price on shares of adidas and gave the company a “buy” rating in a research note on Thursday, August 9th. Finally, Goldman Sachs Group set a €240.00 ($279.07) target price on shares of adidas and gave the company a “buy” rating in a research note on Wednesday, November 7th. Nine analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of €225.17 ($261.83).

Shares of ADS opened at €195.45 ($227.27) on Thursday. adidas has a fifty-two week low of €163.65 ($190.29) and a fifty-two week high of €201.01 ($233.73).

About adidas

adidas AG, together with its subsidiaries, designs, develops, produces, and markets athletic and sports lifestyle products worldwide. It offers footwear; apparel; and hardware, such as bags and balls under the adidas, Reebok, and adidas Golf brands. The company is also involved in Y-3 label business activities; and the operation of Runtastic, a digital health and fitness space.

Featured Article: How To Calculate Debt-to-Equity Ratio

Analyst Recommendations for adidas (FRA:ADS)

Receive News & Ratings for adidas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for adidas and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.